Literature DB >> 28060535

Circulating microRNAs: Promising Biomarkers Involved in Several Cancers and Other Diseases.

Yicheng Zhao1, Yuanyuan Song1, Li Yao1, Guangqi Song2,3, Chunbo Teng1.   

Abstract

Recently, many studies indicated that microRNAs (miRNAs) stably existed in various body fluids, including serum, plasma, saliva, and urine. Such miRNAs that exist in mammalian body fluids are known as circulating miRNAs, and they can transmit signals between cells and regulate intracellular gene expression. Currently, we barely understand the characteristics, sources, secretion, uptake, and functions of newly generated miRNAs. Particularly, it has been shown that certain types of circulating miRNAs can provide effective clinical data, suggesting their roles as novel biomarkers for the early detection of diseases such as cancers, cardiovascular diseases, and diabetes. Therefore, miRNAs have attracted much attention in academia for their promising applications in fundamental research and clinical diagnosis. This review summarizes some of the functional studies that have been conducted as well as the promising applications of circulating miRNAs, and we hope it will benefit other researchers in this field.

Entities:  

Keywords:  biomarkers; cancer; cardiovascular disease; circulating miRNAs; diabetes

Mesh:

Substances:

Year:  2017        PMID: 28060535     DOI: 10.1089/dna.2016.3426

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  22 in total

Review 1.  MicroRNAs: A novel potential biomarker for diagnosis and therapy in patients with non-small cell lung cancer.

Authors:  Qun Zhou; Shao-Xin Huang; Feng Zhang; Shu-Jun Li; Cong Liu; Yong-Yong Xi; Liang Wang; Xin Wang; Qi-Qiang He; Cheng-Cao Sun; De-Jia Li
Journal:  Cell Prolif       Date:  2017-10-08       Impact factor: 6.831

2.  Plasma miR-145 as a novel biomarker for the diagnosis and radiosensitivity prediction of human cervical cancer.

Authors:  Hu Wei; Chen Wen-Ming; Jiao Jun-Bo
Journal:  J Int Med Res       Date:  2017-05-23       Impact factor: 1.671

3.  Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.

Authors:  Yuantao Cui; Yuan Xue; Shangwen Dong; Peng Zhang
Journal:  J Int Med Res       Date:  2017-06-06       Impact factor: 1.671

Review 4.  Pathophysiology and Clinical Utility of Non-coding RNAs in Epilepsy.

Authors:  Yiye Shao; Yinghui Chen
Journal:  Front Mol Neurosci       Date:  2017-08-10       Impact factor: 5.639

5.  Data Mining of Small RNA-Seq Suggests an Association Between Prostate Cancer and Altered Abundance of 5' Transfer RNA Halves in Seminal Fluid and Prostatic Tissues.

Authors:  Joseph M Dhahbi; Hani Atamna; Luke A Selth
Journal:  Biomark Cancer       Date:  2018-02-20

6.  miR-29a is a potential protective factor for fibrogenesis in gluteal muscle contracture.

Authors:  R Zhou; S Ren; C Li; X Zhang; W Zhang
Journal:  Physiol Res       Date:  2020-05-29       Impact factor: 1.881

Review 7.  Panomics for Precision Medicine.

Authors:  Charanjit Sandhu; Alia Qureshi; Andrew Emili
Journal:  Trends Mol Med       Date:  2017-12-05       Impact factor: 15.272

8.  Medical examination powers miR-194-5p as a biomarker for postmenopausal osteoporosis.

Authors:  Haifeng Ding; Jia Meng; Wei Zhang; Zhangming Li; Wenjing Li; Mingming Zhang; Ying Fan; Qiujun Wang; Yina Zhang; Lihong Jiang; Wenliang Zhu
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

9.  Identification of differentially expressed microRNAs in acute Kawasaki disease.

Authors:  Ye Chen; Yue-Yue Ding; Yan Ren; Lei Cao; Qiu-Qin Xu; Ling Sun; Ming-Guo Xu; Hai-Tao Lv
Journal:  Mol Med Rep       Date:  2017-11-08       Impact factor: 2.952

Review 10.  microRNAs Make the Call in Cancer Personalized Medicine.

Authors:  Simone Detassis; Margherita Grasso; Valerio Del Vescovo; Michela A Denti
Journal:  Front Cell Dev Biol       Date:  2017-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.